GLP1 Receptor Agonist Market: Current Landscape, Growth Opportunities and Future Market Outlook
Roots Analysis
AUGUST 1, 2024
Key Restraints High Treatment Costs: The relatively high cost of GLP-1 receptor agonists (when compared to other treatments for treating diabetes and obesity) limits their accessibility; further, patients without comprehensive insurance coverage, may find these medications financially burdensome. per package in the US.
Let's personalize your content